日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age

比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺治疗老年 HIV 感染者：一项针对病毒学抑制的 ≥65 岁患者的 96 周 3b 期开放标签转换试验的结果

期刊:Hiv Medicine
影响因子:3.2
doi:10.1111/hiv.13319
Maggiolo, Franco; Rizzardini, Giuliano; Molina, Jean-Michel; Pulido, Federico; De Wit, Stephane; Vandekerckhove, Linos; Berenguer, Juan; D'Antoni, Michelle L; Blair, Christiana; Chuck, Susan K; Piontkowsky, David; Martin, Hal; Haubrich, Richard; McNicholl, Ian R; Gallant, Joel
HIV
炎症/感染
微生物学
发表日期：2023
文献求助 收藏

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial

比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺治疗病毒学抑制的 HIV 感染者（年龄≥65 岁）：一项 3b 期开放标签试验的第 48 周结果

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-021-00419-5
Maggiolo, Franco; Rizzardini, Giuliano; Molina, Jean-Michel; Pulido, Federico; De Wit, Stephane; Vandekerckhove, Linos; Berenguer, Juan; D'Antoni, Michelle L; Blair, Christiana; Chuck, Susan K; Piontkowsky, David; Martin, Hal; Haubrich, Richard; McNicholl, Ian R; Gallant, Joel
HIV
炎症/感染
微生物学
发表日期：2021
文献求助 收藏

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens

在随机转换为基于恩曲他滨-替诺福韦艾拉酚胺的单片疗法后，使用雷迪派韦/索非布韦进行HIV/HCV治疗

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0224875
Huhn, Gregory D; Ramgopal, Moti; Jain, Mamta K; Hinestrosa, Federico; Asmuth, David M; Slim, Jihad; Goldstein, Deborah; Applin, Shauna; Ryu, Julie H; Jiang, Shuping; Cox, Stephanie; Das, Moupali; Nguyen-Cleary, Thai; Piontkowsky, David; Guyer, Bill; Rossaro, Lorenzo; Haubrich, Richard H
HIV
微生物学
发表日期：2020
文献求助 收藏

[Recommendations for the reopening and activity resumption of the neurogastroenterology units in the face of the COVID-19 pandemic. Position of the Sociedad Latinoamericana de Neurogastroenterología]

[关于在新冠疫情下神经胃肠病科室重新开放和恢复活动的建议。拉丁美洲神经胃肠病学会立场]

期刊:Jaids-Journal of Acquired Immune Deficiency Syndromes
影响因子:2.2
doi:10.1097/QAI.0000000000002595
Perez-Valero, Ignacio; Llibre, Josep M; Castagna, Antonella; Pulido, Federico; Molina, Jean-Michel; Esser, Stefan; Margot, Nicolas; Shao, Yongwu; Temme, Lauren; Piontkowsky, David; McNicholl, Ian R; Haubrich, Richard; Remes-Troche, JM; Valdovinos-Díaz, MA; Viebig, R; Defilippi, C; Bustos-Fernández, LM; Sole, L; Hani-Amador, AC
微生物学
新冠
发表日期：2020
文献求助 收藏

Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials

艾维格拉韦/考比司他/恩曲他滨/富马酸替诺福韦二吡呋酯治疗亚洲人类免疫缺陷病毒1型感染者的疗效和安全性：3期临床试验的亚组分析

期刊:Infection and Chemotherapy
影响因子:2.9
doi:10.3947/ic.2016.48.3.219
Choi, Jun Yong; Sungkanuparph, Somnuek; Anekthananon, Thanomsak; Sax, Paul; DeJesus, Edwin; Edelstein, Howard; Nelson, Mark; DeMorin, Jennifer; Liu, Hui C; Swamy, Raji; Bahn, Joonwoo; Hwang, Sunjin; Yang, Sang Youn; Ng, Christopher; Piontkowsky, David
HIV
炎症/感染
微生物学
Human
免疫/内分泌
发表日期：2016
文献求助 收藏

An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy

埃尔维格拉韦/考比司他/恩曲他滨/富马酸替诺福韦酯与阿巴卡韦/拉米夫定+多替拉韦在初始治疗中的疗效和安全性间接比较

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0155406
M Llibre, Josep; Raffi, François; Moyle, Graeme; Behrens, Georg; Bouee, Stephane; Reilly, Geraldine; Borg, Peter; Piontkowsky, David; Rogatto, Felipe
发表日期：2016
文献求助 收藏

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years

在 ≥50 岁 HIV-1 感染且未接受过治疗的受试者中，E/C/F/TDF 与 EFV/FTC/TDF 和 ATV+RTV+FTC/TDF 的长期疗效和安全性比较

期刊:Journal of the International Aids Society
影响因子:4.9
doi:10.7448/IAS.17.4.19767
Gazzard, Brian; Girard, Pierre Marie; Di Perri, Giovanni; Gallant, Joel; Towner, William; Rogatto, Felipe; Demorin, Jennifer; McColl, Damian; Liu, Hui; Rhee, Martin; Szwarcberg, Javier; Piontkowsky, David
HIV
炎症/感染
微生物学
发表日期：2014
文献求助 收藏

An indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir and dolutegravir + abacavir/lamivudine

间接比较艾维格拉韦/考比司他/恩曲他滨/替诺福韦与多替拉韦+阿巴卡韦/拉米夫定的疗效和安全性

期刊:Journal of the International Aids Society
影响因子:4.9
doi:10.7448/IAS.17.4.19779
Rogatto, Felipe; Bouee, Stephane; Jeanbat, Vivianne; Piontkowsky, David; Aragao, Filipa; Bosse, Matthew
发表日期：2014
文献求助 收藏

Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis

在病毒学抑制的HIV感染成人患者中，改用Stribild与继续使用NVP或RPV联合FTC和TDF相比的疗效比较：STRATEGY-NNRTI亚组分析

期刊:Journal of the International Aids Society
影响因子:4.9
doi:10.7448/IAS.17.4.19793
Stellbrink, Hans-Juergen; Antinori, Andrea; Pozniak, Anton; Flamm, Jason; Bredeek, Fritz; Patel, Kiran; Garner, Will; Piontkowsky, David
HIV
炎症/感染
微生物学
发表日期：2014
文献求助 收藏

Emergency department utilization by HIV-positive adults in the HAART era

高效抗逆转录病毒疗法时代艾滋病毒感染成年人急诊就诊情况

期刊:International Journal of Emergency Medicine
影响因子:2
doi:10.1007/s12245-008-0066-7
Venkat, Arvind; Shippert, Brian; Hanneman, Douglas; Nesbit, Chadd; Piontkowsky, David M; Bhat, Sunil; Kelly, Morgen
HIV
炎症/感染
微生物学
发表日期：2008
文献求助 收藏